| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13D · 1 security · may seek to influence control | ||||||
|
Ventyx Biosciences, Inc.
13D/A
VTYX · 92332V107
|
7.6% |
3/12/2025
Event 3/10/2025
|
||||
| NSV Investments I, L.P. | 4.4% | |||||
| NSV Partners III, L.P. | 6.4% | |||||
| NSV Partners III GP, LLC | 6.4% | |||||
| Somasundaram Subramaniam | 7.6% | |||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.